Concepedia

Author

Owen Stephens

University of Arkansas for Medical SciencesORCID

Also Known As

O Stephens, O W Stephens, O. Stephens, O. W. Stephens, Owen Stephens, Owen W Stephens, Owen W. Stephens, Stephens, Owen, Stephens, Owen W

68

Publications

3.7K

Citations

21

H-Index

49

Concepts

All Affiliations

University of Arkansas for Medical SciencesCancer Research And BiostatisticsLund UniversityHeidelberg UniversityGerman Cancer Research Center
OS

About

Owen Stephens is an author at University of Arkansas for Medical Sciences specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

1.7K

2

Immunology

7

7

1.6K

3

Cell Biology

3

3

215

4

Public Health

1

1

13

5

Molecular Medicine

1

1

929

Owen Stephens

×

22

Publications

3.3K

Citations

19

H-Index

YearCitations

Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

Christina M. Annunziata, R. Eric Davis, Yulia N. Demchenko,

Cancer Cell

2007

929

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

Daniel R. Carrasco, Giovanni Tonon, Yongsheng Huang,

Cancer Cell

2006

424

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Leo Rasche, Shweta S. Chavan, Owen Stephens,

Nature Communications

2017

405

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

Ya‐Wei Qiang, Yu Chen, Owen Stephens,

Blood

2008

242

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

Niels Weinhold, Cody Ashby, Leo Rasche,

Blood

2016

207

High-risk myeloma is associated with global elevation of miRNAs and overexpression of <i>EIF2C2/AGO2</i>

Yiming Zhou, Lijuan Chen, Bart Barlogie,

Proceedings of the National Academy of Sciences

2010

197

Dickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone Formation

Gregory A. Clines, Khalid S. Mohammad, Yongde Bao,

Molecular Endocrinology

2006

177

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3

John D. Shaughnessy, Pingping Qu, Saad Z. Usmani,

Blood

2011

175

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

Simona Colla, Fenghuang Zhan, Wei Xiong,

Blood

2007

90

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification

Owen Stephens, Qing Zhang, Pingping Qu,

Blood

2011

63

Page 1